scispace - formally typeset
R

Radhika Gogoi

Researcher at Geisinger Medical Center

Publications -  47
Citations -  471

Radhika Gogoi is an academic researcher from Geisinger Medical Center. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 10, co-authored 30 publications receiving 361 citations. Previous affiliations of Radhika Gogoi include New York University & Lankenau Medical Center.

Papers
More filters
Journal ArticleDOI

DNA nanotherapy for pre-neoplastic cervical lesions.

TL;DR: An HPV16 DNA sequence that targets gene expression specifically to HPV16-infected cells remains to be discovered, and topical application of a Lutrol F127 thermal gel/nanoparticle mix is illustrative of how to restrict exposure of cells to therapeutic nanoparticles, thereby allowing for targeted DNA delivery to cervical pre-cancerous lesions.
Journal ArticleDOI

Evaluation of Society of Gynecologic Oncologists (SGO) ovarian cancer quality surgical measures

TL;DR: This study sets benchmarks for evaluation of documentation in gynecologic oncology centers and shows that improved documentation and staging will allow for equivalent standards of care across institutions.
Journal ArticleDOI

Differential gene expression induced by Verteporfin in endometrial cancer cells.

TL;DR: RNA sequencing data revealed multiple key genes of pathological significance in EMCA, thereby improving the understanding of molecular profiles of EMCA cells and indicating that subcutaneous tumors in mice were regressed after VP treatment by inhibiting cell cycle pathway proteins.
Journal ArticleDOI

The activity of medroxyprogesterone acetate, an androgenic ligand, in ovarian cancer cell invasion.

TL;DR: Although classified as a progestin, medroxyprogesterone acetate has significant androgenic activity unique from the pure androgen dihydrotestosterone, and these studies suggest that pharmacologic doses of medroxy Prozac may actually increase the invasive potential of epithelial ovarian cancer cells.